Статті в журналах: "Durling"

1

TEIGEN, P. M. "In Memoriam: Richard J. Durling." Journal of the History of Medicine and Allied Sciences 55, no. 2 (April 1, 2000): 179–81. http://dx.doi.org/10.1093/jhmas/55.2.179.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Freeman, Eric. "Richard J Durling (1932–1999)." Medical History 44, no. 1 (January 2000): 111. http://dx.doi.org/10.1017/s0025727300066102.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Martinez, Ronald L. "Robert M. Durling (1929–2015)." Dante Studies 133, no. 1 (2015): 191–95. http://dx.doi.org/10.1353/das.2015.0005.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Fortuna, Stefania, and Annamaria Raia. "Corrigenda and Addenda to Diels' Galenica by Richard J. Durling: III. Manuscripts and Editions." Traditio 61 (2006): 1–30. http://dx.doi.org/10.1017/s0362152900002841.

Повний текст джерела

Анотація:

Richard Jasper Durling (1932–1999) made many important contributions to the study of the Latin tradition and critical edition of the works of Galen (AD 129–216), the Greek physician who was a notable figure in the history of medicine from late antiquity to the eighteenth century.

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Smith, Wesley D. "A Dictionary of Medical Terms in Galen. Richard J. Durling." Isis 85, no. 2 (June 1994): 306–7. http://dx.doi.org/10.1086/356826.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

6

TAKAHAMA, Makoto, Hajime YAMASAKI, Keiji KUWATA, Yoshiro YAMASAKI, Tsunenori FUJITA, Takahiro YAMAGUCHI, and Yasushi KOBAYASHI. "AN OPERATED CASE OF UNILOCULAR BILIARY CYSTADENOMA WITH INTRATUMORAL EXPANSION DURLING FOUR YEARS." Journal of the Japanese Practical Surgeon Society 55, no. 5 (1994): 1248–52. http://dx.doi.org/10.3919/ringe1963.55.1248.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Ascoli, Albert Russell. "Time and the Crystal: Studies in Dante's "Rime petrose.". Robert M. Durling , Ronald L. Martinez." Speculum 68, no. 3 (July 1993): 751–53. http://dx.doi.org/10.2307/2864992.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

8

Krause, Kathy M. "Jean Renart and the Art of Romance: Essays on "Guillaume de Dole".Nancy Vine Durling." Speculum 75, no. 1 (January 2000): 174–76. http://dx.doi.org/10.2307/2887443.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

9

Cooksey, Thomas L. "Robert M. Durling and Ronald L. Martínez.Time and the Crystal: Studies in Dante's “Rime Petrose.”." Romance Quarterly 39, no. 2 (May 1992): 251–52. http://dx.doi.org/10.1080/08831157.1992.10544999.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

10

Castellani, Victor. "Time and the Crystal: Studies in Dante's Rime Petrose. Robert M. Durling , Ronald L. Martinez." Modern Philology 90, no. 3 (February 1993): 409–13. http://dx.doi.org/10.1086/392088.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

11

Jones, Peter Murray. "Galen's Method of Healing: Proceedings of the 1982 Galen Symposium. Fridolf Kudlien , Richard J. Durling." Isis 83, no. 3 (September 1992): 484–85. http://dx.doi.org/10.1086/356227.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

12

Kleinhenz, Christopher. "Time and the Crystal: Studies in Dante's "Rime Petrose.". Robert M. Durling , Ronald L. Martinez." Isis 83, no. 4 (December 1992): 650. http://dx.doi.org/10.1086/356311.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

13

OHBA, Shohachi. "Construction of Tokaido Railway in Shizuoka Prefecture durling the 1880s and the Attitude of Regional Society." Geographical Review of Japa,. Ser. A, Chirigaku Hyoron 67, no. 12 (1994): 833–57. http://dx.doi.org/10.4157/grj1984a.67.12_833.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

14

Fortuna, Stefania, and Annamaria Raia. "Corrigenda and Addenda to Diels' Galenica by Richard J. Durling: III. Manuscripts and Editions." Traditio 61, no. 1 (2006): 1–30. http://dx.doi.org/10.1353/trd.2006.0005.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

15

Cachey,, Theodore J. "The Divine Comedy of Dante Alighieri, 1: Inferno.Dante Alighieri , Robert M. Durling , Ronald L. Martinez , Robert Turner." Speculum 74, no. 2 (April 1999): 400–403. http://dx.doi.org/10.2307/2887067.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

16

Havely, N. "Review: Second Best? Translating Purgatorio * Robert M. Durling: The Divine Comedy of Dante Alighieri: Volume 2: Purgatorio." Cambridge Quarterly 33, no. 4 (April 1, 2004): 367–71. http://dx.doi.org/10.1093/camqtly/33.4.367.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

17

Basile, Paola. "Robert M Durling (a cura di e tradotto da), The Divine Comedy of Dante Alighieri: Volume III: Paradiso." Forum Italicum: A Journal of Italian Studies 49, no. 1 (February 10, 2015): 230–32. http://dx.doi.org/10.1177/0014585815570822.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

18

Vallance, J. T. "(F.) Kudlien and (R.J.) Durling Ed.Galen's method of healing: proceedings of the 1982 Galen symposium. Leiden: Brill, 1991. Pp. viii + 205. Fl. 110." Journal of Hellenic Studies 113 (November 1993): 197–98. http://dx.doi.org/10.2307/632431.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

19

Siraisi, Nancy G. "Arnaldi de Villanova opera medica omnia. Volume XV: Commentum supra tractatum Galieni De malicia complexionis diverse. Arnald of Villanova , Luis Garcia Ballester , Eustaquio Sanchez SalorDoctrina Galieni De Interioribus. Richard J. Durling." Isis 77, no. 2 (June 1986): 367–68. http://dx.doi.org/10.1086/354179.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

20

King, Helen. "Galen's Terminology - R. J. Durling: A Dictionary of Medical Terms in Galen. (Studies in Ancient Medicine, 5.) Pp. xiii+344. Leiden, New York, Cologne: E. J. Brill, 1993. Cased, Gld. 200/$114.50." Classical Review 45, no. 1 (April 1995): 139–40. http://dx.doi.org/10.1017/s0009840x00292603.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

21

van der Eijk, Philip. "RICH. J. DURLING (ed.), Galenus Latinus II. Burgundio of Pisa's Translation of Galen's Περι των ΠεΠονότων τόΠων “De interioribus” (Ars Medica, Abt. II, Band 6.2), 2 Bde. Stuttgart, Franz Steiner Verlag, 1992. 451 pp." Mnemosyne 49, № 5 (1996): 596–98. http://dx.doi.org/10.1163/1568525962610455.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

22

Hankinson, R. J. "Fridolf Kudlien and Richard J. Durling (eds), Galen's method of healing, Proceedings of the 1982 Galen Symposium, Studies in Ancient Medicine series, Leiden, E. J. Brill, 1991, pp. viii, 205, DFl. 110.00 (90-04-09272-2)." Medical History 36, no. 2 (April 1992): 236–37. http://dx.doi.org/10.1017/s0025727300055198.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

23

King, Helen. "Galen's Method Fridolf Kudlien, Richard J. Durling (edd.): Galen's Method of Healing. Proceedings of the 1982 Galen Symposium. (Studies in Ancient Medicine, 1.) Pp. viii + 205. Leiden, New York, Copenhagen and Cologne: Brill, 1991. fl. 110." Classical Review 42, no. 01 (April 1992): 170–71. http://dx.doi.org/10.1017/s0009840x00282802.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

24

Burkert, Walter. "Richard J. Durling, A Dictionary of Medical Terms in Galen. Leiden, New York, Köln, E. J. Brill, 1993. XIII, 344 S. (Studies in Ancient Medicine, vol.5). Hfl.200.-; USS 114,50. ISBN 90-04-09754-6; ISSN 0925-1421." Gesnerus 51, no. 3-4 (November 27, 1994): 310–11. http://dx.doi.org/10.1163/22977953-0510304026.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

25

Fortuna, Stefania. "Richard J. Durling (ed.), Galenus Latinus II: Burgundio of Pisa's translation of Galen's ΠEPI TΩN ΠEΠONΘOTΩN TOΠΩN “De interioribus”2 vols, Ars Medica Abt. II., 6/2A, 6/2B, Stuttgart, Franz Steiner, 1992, pp. 450, DM 178.00 (3-515-04363-2)." Medical History 37, № 3 (липень 1993): 350–51. http://dx.doi.org/10.1017/s0025727300058580.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

26

Gaggi, Silvio. "Reply to Steven Durland." Leonardo 19, no. 4 (1986): 357. http://dx.doi.org/10.2307/1578397.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

27

Jacquart, Danielle. "Galenus latinus II: Burgundio of Pisa’s translation of Galen’s Peri ton peponthoton topôn, «De interioribus». Ed. with introd. and indices by Richard J. Durling. Stuttgart, Steiner, 1992.2 vols. (Ars Medica, II, 6/2A, 6/2B). DM 178.-. ISBN 3-515-04363-2." Gesnerus 52, no. 1-2 (November 27, 1995): 172–73. http://dx.doi.org/10.1163/22977953-0520102023.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

28

Evergates, Theodore. "Cartulaire de Saint-Nicaise de Reims.Jeannine Cossé-Durlin." Speculum 69, no. 2 (April 1994): 449–50. http://dx.doi.org/10.2307/2865112.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

29

Kise, T., E. Takamasu, Y. Miyoshi, N. Yokogawa, and K. Shimada. "THU0309 UNILATERAL TEMPORAL ARTERY BIOPSY IS SUFFICIENT FOR DIAGNOSING GIANT CELL ARTERITIS IF THE SERUM C-REACTIVE PROTEIN LEVEL IS 10 MG/DL OR HIGHER." Annals of the Rheumatic Diseases 79, Suppl 1 (June 2020): 383–84. http://dx.doi.org/10.1136/annrheumdis-2020-eular.458.

Повний текст джерела

Анотація:

Background:Temporal artery biopsy (TAB) is the gold standard for diagnosing giant cell arteritis (GCA). However, previous studies have reported that the discordance rate of TAB is 3-45%,i.e., in unliteral TAB, GCA may be overlooked in one in five patients, approximately. Evidence as to whether bilateral TAB should be performed initially or one-sided TAB is sufficient for diagnosing GCA is lacking.Objectives:To investigate the predictors of patients with GCA in whom one-sided TAB is sufficient.Methods:The present study was a cross-sectional, single center study conducted from April 1, 2011 to July 31, 2019 at Tokyo Metropolitan Tama Medical Center. Of all consecutive GCA cases for which bilateral TAB was performed, bilaterally positive cases and unilaterally positive cases were extracted as bilateral positive group (BPG) and unilateral positive group (UPG), respectively. GCA was defined in accordance with the classification criteria of the 1990 American College of Rheumatology, and GCA was diagnosed if no other etiology was found within six months after beginning of high-dose glucocorticoid treatment. Demographic, clinical and laboratory data were obtained from the medical records, and the BPG and the UPG were compared statistically in each variable. Statistical significance was defined asp< 0.05.Results:During study, 264 biopsies were performed for 145 cases, who suspected GCA and underwent TAB. The pathological positivity rate was 26.1% (68 / 264 biopsies). Of these, 53 cases had final diagnosis of GCA, in which 43 cases were biopsy proven GCA. Thirty-seven biopsy proven GCA with bilateral TAB were enrolled; 64.9% women; mean (SD) age 75 (8.9) years; median [IQR] TAB length 17.5 [13.0,20.0] mm; headache 54.1%; jaw claudication 45.9%; scalp tenderness 16.2%; temporal artery (TA) tenderness 32.4%; TA engorgement 32.4%; TA pulse abnormality 5.4%; visual symptoms 2.7%; a fever of 38.5°C or higher 40.5%; shoulder girdle pain 48.6%; imaging of aortitis or arteritis 40.5%; median [IQR] white blood cell 9,100 [7200, 12050] /μl; median [IQR] platelet cell 37.5 [27.0, 46.3] ×104/μl; median [IQR] C-reactive protein (CRP) 10.1 [3.9, 16.5] mg/dL; erythrocyte sedimentation rate [IQR] 105 [66, 129] mm/h. Thirty-one in 37 cases were positive bilaterally while 6 in 37 cases were positive unilaterally; and the discordance rate was 16.2%. The median sample length after formalin fixation was 19.0 mm for the BPG and 14.5 mm for the UPG (p= 0.171). The parameters above were compared between UPG and BPG. Of these, only the serum CRP value (mg/dL) differed statistically between groups, and the median value of the two groups was 10.6 and 6.5, respectively (median test:p= 0.031). To predict BPG, in whom unilateral TAB is sufficient for diagnosing GCA, the cut-off value of serum CRP with a specificity of 100% and a sensitivity of 61.3% was set at 9.3 mg/dL (ROC analysis: AUC 0.726).Conclusion:When the serum CRP level is 10 mg/dL or higher in GCA suspected patients, an unilateral TAB alone was sufficient for an accurate diagnosis.References:[1]Hellmich, B, et al.Ann Rheum Dis2020;79(1):19-30.[2]Breuer, GS, et al.J Rheumatol. 2009;36(4):794-796.[3]Czyz CN, et al.Vascular2019;27(4):347-351.[4]Durling B, et al.Can J Ophthalmol2014;49(2):157-161.Figure.Comparison of median CRP levels between unilaterally positive group and bilaterally positive group.Disclosure of Interests:None declared

Стилі APA, Harvard, Vancouver, ISO та ін.

30

Bayrou, Lucien, Patrice Alessandri, Michel Barrere, Patrick Bonnet, Christian Bouvier, Jean-Paul Cazes, Bernadette Delva, et al. "Peyrepertuse. Forteresse royale [Préface de Marcel Durliat ]." Archéologie du Midi médiéval 3, no. 1 (2000): 3–288. http://dx.doi.org/10.3406/amime.2000.1505.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

31

Young, Thomas. "HIGH PERFORMANCE. v. 1-, no. 1. Steve Durland." Art Documentation: Journal of the Art Libraries Society of North America 6, no. 2 (July 1987): 93. http://dx.doi.org/10.1086/adx.6.2.27947757.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

32

Durland, Logan. "Lessons Learned: Conducting Cases of Manualized, Telephone-Based, Cognitive Behavioral Treatment for Depression in Parkinson’s Disease (dPD)." Pragmatic Case Studies in Psychotherapy 16, no. 1 (July 26, 2020): 124–31. http://dx.doi.org/10.14713/pcsp.v16i1.2071.

Повний текст джерела

Анотація:

My current clinical practice has been shifted to a telehealth format for the last three months due to the COVID-19 pandemic, and it seems an apt moment to reexamine my participation in Dr. Roseanne Dobkin’s research on manualized telehealth therapy for depression in Parkinson’s disease patients (dPD), using a protocol titled "Teleheath Guided Self-Help for dPD," or "TH-GSH-dPD," for short (Dobkin et al., 2020). My participation involved, in part, being the therapist in four case studies I have written about with "Alice," "Carl," "Ethan," and "Gary" (Durland, 2020). In these case studies, a subset of those in Dr. Dobkin’s group studies, I explored my clinical decision-making, seeking insight into how best to flexibly apply the dPD protocol to meet the needs of a heterogeneous clinical population. Here, my aim is to recontextualize and expand on the conclusions of my four case studies, based on my dissertation and conducted over three years ago (Durland, 2017), in light of both my recent experience providing mental health services and the Commentaries on the four case studies so perceptively contributed by Dr. Dobkin and her colleagues (Mann, Miller, St. Hill, Dobkin, 2020) and by Liza Pincus (2020). In particular, I will focus first on (a) continuing the analysis of clinical decision-making involved in the case studies described in my earlier article (Duland, 2020); and then on (b) general issues related to the delivery of telehealth treatment.

Стилі APA, Harvard, Vancouver, ISO та ін.

33

Anno, S., T. Okano, K. Inui, T. Koike, and H. Nakamura. "AB0235 DENOSUMAB INCREASE THE BONE MINERAL DENSITY REGARDLESS OF DISEASE ACTIVITY, THE BIOLOGICAL DISEASE-MODIFYING ANTIRHEUMATIC DRUGS, THE CONCOMITANT TYPE OF VITAMIN D, AND PRETREATMENT OF OSTEOPOROSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS." Annals of the Rheumatic Diseases 79, Suppl 1 (June 2020): 1417.2–1418. http://dx.doi.org/10.1136/annrheumdis-2020-eular.2538.

Повний текст джерела

Анотація:

Background:Osteoporosis is one of the major comorbidities in patients with rheumatoid arthritis (RA). There are a lot of evidence that denosumab increase bone mineral density (BMD) in patients with osteoporosis. However, there are few reports investigated the influence of denosumab in patients with RA.Objectives:We evaluated the BMD change in patients with RA treated denosumab and assessed the effect of various factors, such as disease activity, biological disease-modifying anti-rheumatic drugs (bDMARDs) use, concomitant medications of osteoporosis and pretreatment of osteoporosis.Methods:This study included 140 consecutive RA patients (135 female, mean age was 70.6 ± 8.6 years) who fullfilled the criteria of osteoporosis and treated with denosumab. BMD at the lumbar spine, proximal femoral and femoral neck were evaluated by dual energy X-ray absorptiometry at baseline and one year after treatment. We evaluated the influence of disease activity, bDMARDs use, the concomitant type of vitamin D and pretreatment of osteoporosis for BMD change.Results:BMD change at the lumbar spine, proximal femoral and femoral neck were 5.9% (p<0.01), 4.0% (p<0.01), and 1.2% (p=0.36) durling one year. There were no differences in improvement ratio of BMD between each parameters (fig 1). Disease activity: 75 patients in remission or low disease activity and 65 patients in moderate or high disease activity were 6.4 vs 5.3% (p=0.91), 3.0 vs 5.1% (p=0.73), 2.0 vs 0.3% (p=0.1). bDMARDs: 45 patients with bDMARDs (anti-tumor necrosis factor inhibitors (TNF): 23, tocilizmab (TCZ): 13, abatacept (ABT): 7, Tofacitinib: 2) and 93 patients without bDMARDs were 6.0 vs 5.8% (p=0.31), 4.3 vs 4.1% (p=0.57), -0.2 vs 1.8% (p=0.18). Type of vitamin D: 47 patients taking active form vitamin D and 60 patients taking native form vitamin D were 5.5 vs 6.8% (p=0.82), 3.1 vs 3.8% (p=0.93), 0.4 vs 1.9% (p=0.14). Pretreatment of osteoporosis: 74 patients with pretreatment of osteoporosis (bisphosphonate:58, teriparatide:16) and 66 patients without pretreatment of osteoporosis were 6.9 vs 5.4% (p=0.41), 0.9 vs 4.0% (p=0.22), 2.0 vs 1.2% (p=0.68). Moreover, BMD change were not different in bDMARDs type, 5.0, 6.4, 0.5% in TNF group, 4.8, 0.7, -1.9% in TCZ group, 9.7, 4.9, 0.2% in ABT group (TNF vs TCZ: p=0.83, 0.98, 0.81, TNF vs ABT: p=0.83, 0.41, 0.97, TCZ vs ABT: p=0.98, 0.43, 0.9). There were no difference between bisphosphonate and teriparatide (6.2 vs 6.9%: p=0.49, 4.8 vs 0.9%: p=0.35, 0.9 vs 2.0%: p=0.49).Conclusion:Denosumab improved BMD in patients with RA independently regardless of disease activity, bDMARDs, the concomitant type of vitamin D and pretreatment of osteoporosis.References:[1]Y Nakamura et al, Arch Osteoporos: 2017; 12:80.[2]K Kaneko et al, Journal of Experimental Orthopaedics: 2019; 6:41.[3]T Suzuki et al, Therapeutics and Clinical Risk Management: 2018; 14:453–459.Acknowledgments:We wish to thank Atsuko Kamiyama, Tomoko Nakatsuka, Masato Uematsu and all participants in this study.Disclosure of Interests:Shohei Anno: None declared, Tadashi Okano Grant/research support from: AbbVie, Eisai, Mitsubishi Tanabe Pharma Corporation and Nipponkayaku, Speakers bureau: AbbVie, Asahikasei, Astellas Pharma Inc, Ayumi Pharmaceutical, Bristol-Myers Squibb, Chugai Pharmaceutical, Daiich Sankyo, Eisai, Janssen, Lilly, Mitsubishi Tanabe Pharma Corporation, Novartis Pharma, Ono Pharmaceutical, Pfizer, Sanofi, Takeda Pharmaceutical, Teijin Pharma and UCB, Kentaro Inui Grant/research support from: Janssen Pharmaceutical K.K., Astellas Pharma Inc., Sanofi K.K., Abbvie GK, Takeda Pharmaceutical Co. Ltd., QOL RD Co. Ltd., Mitsubishi Tanabe Pharma, Ono Pharmaceutical Co. Ltd., Eisai Co.,Ltd.,, Speakers bureau: Daiichi Sankyo Co. Ltd., Mitsubishi Tanabe Pharma, Janssen Pharmaceutical K.K., Astellas Pharma Inc., Takeda Pharmaceutical Co. Ltd., Ono Pharmaceutical Co. Ltd., Abbvie GK, Pfizer Inc., Eisai Co.,Ltd., Chugai Pharmaceutical Co., Ltd., Tatsuya Koike Grant/research support from: AbbVie, Astellas Pharma Inc, Bristol-Myers Squibb, Chugai Pharmaceutical, Eisai, Janssen, Lilly, Mitsubishi Tanabe Pharma Corporation, MSD, Ono Pharmaceutical, Pfizer, Roche, Takeda Pharmaceutical, Teijin Pharma, and UCB, Speakers bureau: AbbVie, Astellas Pharma Inc, Bristol-Myers Squibb, Chugai Pharmaceutical, Eisai, Janssen, Lilly, Mitsubishi Tanabe Pharma Corporation, MSD, Ono Pharmaceutical, Pfizer, Roche, Takeda Pharmaceutical, Teijin Pharma, and UCB, Hiroaki Nakamura Grant/research support from: Astellas Pharma Inc. and Asahi Kasei Pharma Co.

Стилі APA, Harvard, Vancouver, ISO та ін.

34

Lloyd, G. E. R. "Richard J. Durling (ed.): Galenus Latinus II. Burgundio of Pisa's Translation of Galen's ΠΕΡΙ ΤΩΝ ΠΕΠΟΝΘΟΤΩΝ ΤΟΠΩΝ ‘De interioribus’. (Ars Medica II Abteilung. Griechisch-Lateinische Medizin. Band 6/2 B.) Vol. 1, Introduction and Text. Pp. 1–178. Vol. 2, Critical Notes and Indices. Pp. 185–450. Stuttgart: Franz Steiner, 1992. Paper, DM 178." Classical Review 43, № 2 (жовтень 1993): 423. http://dx.doi.org/10.1017/s0009840x0028815x.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

35

Khanna, Sabita Aryal, Kundan Lal Shrestha, Ramesh Kumar Maskey, Alaka Lamsal, Keshab Pyakurel, Manisha Poudyal, Manish Ranjit, Drishtant Karki, Ranjan Aryal, and Ashish Shrestha. "Integrated Water Resource Management (IWRM): A Case Study of Durlung Watershed, Bagmati Zone, Nepal." Hydro Nepal: Journal of Water, Energy and Environment 18 (March 15, 2016): 47–54. http://dx.doi.org/10.3126/hn.v18i0.14645.

Повний текст джерела

Анотація:

Water in Nepal is a key strategic natural resource, which has the potential to lead the all round development and economic growth of the country. Integrated Water Resource Management (IWRM) is a holistic management approach, integrating land water interaction, socio economic groups, upstream downstream relations, indigenous knowledge, and institutions built up, along the temporal dimensions based on an agreed set of principles. It is a bottom-up decentralized approach for the management of water resources. IWRM is a challenge to conventional practices, attitudes and professional certainties. It confronts entrenched sectoral interest & requires that the water resources are managed holistically for the benefits of all.The broad objective of the multidisciplinary study was to assess the possibilities of Human Dimensions of water resource development and its management. Water resource accounting is done by the collection of water resources data through participatory group formation. Scientific data of hydro and metrological stations was also acquired. Hydrological modeling tools were also used. Feasibility of hydropower plant and potential of power production in the basin was readily estimated.Total daily discharge of the Durlung Watershed was estimated on an average of 157 Million Liters. Rivers of the watershed are turbulent, unsteady & flowing with very high current, which can be utilized by local people for low cost drinking water, tourism, irrigation & hydropower generation. Micro-hydropower production possibilities in Ratan and Deuta rivers have shown multidimensional positive impacts on socio-economic development of the region. Level of community partnership in IWRM and synchronization with the local, district & national level institutional framework for Basin Management was observed to be satisfactory. Participatory research was carried to identify water resource base with school & community partnership. Community motives, their difficulties and gaps in community level organization were identified. For capabilities of community to take over the responsibilities of IWRM concept, there is a lot more need of training and capacity building for now. HYDRO Nepal Journal of Water Energy and EnvironmentVolume- 18, 2016, JanuaryPage -47 to 54

Стилі APA, Harvard, Vancouver, ISO та ін.

36

NAKAMURA, Eiji, and Takayuki FUJINO. "A CASE OF SEVOFLURANE INDUCED MALIGNANT HYPERTHERMIA DURlNG ELECTIVE GRAFT REPLACEMENT FOR AN ABDOMINAL AORTIC ANEURYSM." Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) 71, no. 9 (2010): 2291–95. http://dx.doi.org/10.3919/jjsa.71.2291.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

37

Elm, Susanna. "De la Ville Antique à la Ville Byzantine: Le Problème des Subsistances.Jean Durliat." Speculum 68, no. 4 (October 1993): 1107–9. http://dx.doi.org/10.2307/2865528.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

38

Hofstetter, Josef. "Jean Durliat, De la ville antique à la ville byzantine. Le problème des subsistances." Zeitschrift der Savigny-Stiftung für Rechtsgeschichte. Romanistische Abteilung 112, no. 1 (August 1, 1995): 624–28. http://dx.doi.org/10.7767/zrgra.1995.112.1.624.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

39

SAWASIMA, Tomoaki, Naoki MATSUBARA, Yoshihito KURAZUMI, Sayoko MATSUBARA, and Mari ARAI. "A CASE STUDY OF THE THERMAL ENVIRONMENT IN PREFABRICATED HOUSES AND THEIR RESIDENTS' LIFESTYLE IN THE KANSAI AREA DURlNG WlNTER." Journal of Architecture and Planning (Transactions of AIJ) 67, no. 554 (2002): 69–76. http://dx.doi.org/10.3130/aija.67.69_3.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

40

Macêdo, Lenilda Cordeiro de, and Mariana Pereira de Souza. "Educação infantil: políticas e práticas no contexto da pandemia em municípios paraibanos." Zero-a-Seis 24, no. 45 (March 21, 2022): 238–64. http://dx.doi.org/10.5007/1518-2924.2022.e84923.

Повний текст джерела

Анотація:

Esta pesquisa buscou analisar as ações de secretarias de educação e de instituições de educação infantil, de municípios paraibanos, no tocante às atividades pedagógicas, não presenciais e/ou remotas no contexto da pandemia. As fontes de pesquisas compõem-se de normas emitidas pelo governo federal, MEC e CNE: Leis, Pareceres, Portarias e Resoluções (BRASIL, 2020a, 2000b, 2000c,); além de autores como: Campos e Durli (2021); Campos et al (2020), dentre outros. É uma pesquisa de caráter qualitativo, na qual foi realizada uma pesquisa bibliográfica e um questionário para a produção dos dados. Os resultados evidenciaram que, apesar de portarias, pareceres e resoluções elaborados, em nível nacional e estadual, políticas e programas, intersetoriais, não se materializaram para garantir a igualdade no acesso e a qualidade do atendimento. Em face do exposto, pode-se afirmar que as propostas de atividades remotas, na educação infantil são precárias e excludentes.

Стилі APA, Harvard, Vancouver, ISO та ін.

41

Wallinga, Tammo. "Jean Durliat, Les rentiers de l'impôt. Recherches sur les finances municipales dans la pars Orientis au IVe siècle." Zeitschrift der Savigny-Stiftung für Rechtsgeschichte. Romanistische Abteilung 112, no. 1 (August 1, 1995): 557–60. http://dx.doi.org/10.7767/zrgra.1995.112.1.557.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

42

Mann, Sarah L., Rachael Miller, Lauren St. Hill, and Roseanne D. Dobkin. "Individualizing Evidence-Based Treatment of Neuropsychiatrically Complex Patients: Process-Based Targets for Change in Parkinson’s Depression." Pragmatic Case Studies in Psychotherapy 16, no. 1 (July 26, 2020): 104–17. http://dx.doi.org/10.14713/pcsp.v16i1.2069.

Повний текст джерела

Анотація:

Providing evidence-based treatment always requires responding in the moment to apparent gaps between the protocol and the patient’s presenting needs and preferences. In the treatment of depression in Parkinson’s disease (PD), research has shown that providing PD-specialized, empirically supported interventions is paramount. However, given PD’s highly heterogeneous symptom presentations, adapting and individualizing treatment to address each patient’s unique constellation of neuropsychiatric symptoms and PD-related physical challenges is equally important. This Commentary on the article by Dr. Logan Durland (2020) focuses on the importance of attending to process-based factors to inform protocol adaptations in the treatment of Parkinson’s depression, guided by the framework of functional analytic psychotherapy (FAP). The FAP approach applies behavioral principles to in-session processes as a means of highlighting and therapeutically targeting clinically relevant behaviors in real time. Seeking such opportunities to foster within-session change may be especially important when providing evidence-based treatment to individuals with co-occurring mental health issues and chronic, functionally limiting medical problems like PD. As these patients manage the interactions between the complex demands of illness self-management and the burden of mental health symptoms, they must respond adaptively to unpredictable daily challenges. Harnessing moments of clinically relevant struggle during sessions in order to support and reinforce new responses—including new ways of approaching the learning process itself—can help patients consolidate both the coping skills themselves and flexibility and confidence to apply them.

Стилі APA, Harvard, Vancouver, ISO та ін.

43

KATSUKI, Yuji. "THE COMPOSITION OF THE COMMON-USE ROOMS OF JAPANESE HOTELS IN CITIES DURlNG MEIJI, TAISHO AND EARLY SHOWA PERIOD : Historical study of Japanese hotels as urban facilities." Journal of Architecture and Planning (Transactions of AIJ) 67, no. 559 (2002): 275–81. http://dx.doi.org/10.3130/aija.67.275_4.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

44

Brown, D. W. "God or Nations: Radical Theology for the Religious Peace Movement. By William Durland. Baltimore: Fortkamp Publishing Company, 1989. 309 pp. $16.95." Journal of Church and State 32, no. 4 (September 1, 1990): 894–95. http://dx.doi.org/10.1093/jcs/32.4.894-a.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

45

Depeyrot, Georges. "Jean Durliat, Les finances publiques de Dioclétien aux Carolingiens (284-889), Sigmaringen, Thorbecke, « Beihefte der Francia, Bd 21 », 1990, 368 p." Annales. Histoire, Sciences Sociales 50, no. 5 (October 1995): 1121–23. http://dx.doi.org/10.1017/s0395264900056602.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

46

Carrié, Jean-Michel. "Jean Durliat, De la ville antique à la ville byzantine. Le problème des subsistances, Rome, « École Française de Rome », vol. 136, 1990, 642 p." Annales. Histoire, Sciences Sociales 48, no. 5 (October 1993): 1145–50. http://dx.doi.org/10.1017/s0395264900058443.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

47

Durland, Logan. "Telephone-Based, Clinician-Guided Self-Help Cognitive Behavioral Therapy for Depression in Parkinson's Disease (dPD): The Responder Cases of "Alice" and "Carl," and the Nonresponder Cases of "Ethan" and "Gary"." Pragmatic Case Studies in Psychotherapy 16, no. 1 (July 26, 2020): 1–103. http://dx.doi.org/10.14713/pcsp.v16i1.2068.

Повний текст джерела

Анотація:

Roseanne Dobkin and her colleagues (e.g., Dobkin, Interian, Durland, Gara, Menza, 2018) have developed a 10-session, individual cognitive-behavioral treatment (CBT) program for treating depression in individuals with Parkinson’s disease (dPD). The program has been found to yield statistically and clinically significant success in both uncontrolled group trial designs and randomized clinical trials—originally in a face-to-face version, and then in a telehealth version, using telephone therapy sessions and guided self-help materials for patients. This latter version is herein called "Teleheath Guided Self-Help for dPD," or "TH-GSH-dPD," for short. Applying Fishman, Messer, Edwards, and Dattilio’s (2017) "case studies within psychotherapy trials" methodological model, the present research was designed to complement the group research findings by my conducting systematic, pragmatic case studies (Fishman, 2013) with four patients representative of those in the telehealth studies, given the names of "Alice" (and her caregiver husband "Bob"); "Carl" (and his caregiver wife "Doris"); "Ethan" (and his caregiver wife, "Fay"); and "Gary" (and his caregiver mother, not named). Specifically, Alice and Carl were representative of those patients in the group studies with positive, responsive outcomes; and Ethan and Gary were representative of those patients in the group studies with negative, nonresponsive outcomes. Each case combines (a) quantitative data, comprised of demographic information, psychiatric diagnostic data, neurocognitive data, caregiver distress, and treatment outcome measures; and (b) qualitative data, consisting of recordings of the telephone therapy sessions, my treatment notes, my observations as the therapist, and systematic, post-treatment "Exit Interviews" I conducted with each of the patients and their caregivers about their therapy experience. Each of the four case studies aims (a) to provide a detailed, thickly described portrait of the TH-GSH-dPD treatment process; and (b) to explore the presence and influence of barriers and facilitators of treatment in an idiographic context. Regarding point (b), the following variables that cut across the case studies are explored as appearing to be particularly impactful: patients’ worldviews, patients’ cognitive functioning, caregiver involvement, and homework adherence.

Стилі APA, Harvard, Vancouver, ISO та ін.

48

Brandt, Andressa Graziele. "CURRÍCULO DOS CURSOS DE LICENCIATURA EM PEDAGOGIA A PARTIR DAS DCNCP (2006)." Revista Expressão Católica 8, no. 2 (December 18, 2019): 53. http://dx.doi.org/10.25190/rec.v8i2.3718.

Повний текст джерела

Анотація:

O presente texto busca equacionar o movimento de constituição das Diretrizes Curriculares Nacionais para o Curso de Pedagogia (DCNCP), aprovada pela resolução MEC/CNE nº 1, de 15 de maio de 2006. Delimitamos como objetivo refletir sobre a constituição das DCNCP (2006) e a reformulação dos PPCs através de suas proposições de formação do pedagogo. Partimos do seguinte problema de pesquisa: Quais são os significados sociais e historicamente válidos nos desenhos curriculares do curso de Pedagogia ao longo da sua constituição? Apresentamos a constituição histórica dos desenhos curriculares do curso de pedagogia de aspectos conceituais sobre currículo e o desenvolvimento curricular dos professores. Essa pesquisa de caráter qualitativo-descritivo está fundamentada em pesquisadores como: Bissolli da Silva (2003); Brzezinski, (1996); Durli (2007); Gatti (2003), Pimenta at al (2017); Pacheco (2007); Saviani (2009), Sacristán (2003); Nóvoa (1992); entre outros. Os resultados apontaram a constituição dos desenhos curriculares dos cursos de licenciatura de Pedagogia, a partir das suas reformulações fomentadas pelas DCNCP (2006). Constatamos que a formação proposta carece de uma análise profunda, após uma década de implantação e realização de formação de professores para a educação infantil, anos iniciais do ensino fundamental, gestão e espaços não escolares; que é a proposição de formação profissional do pedagogo que tem por base a constituição da docência; por fim, que o objeto de estudo carece de novas e profundas investigações do campo da pedagogia no Brasil.

Стилі APA, Harvard, Vancouver, ISO та ін.

49

Howard, Caleigh, Shu Wiley, Wenzhao Dong, Andrea Mendiola, Veronica Partridge, Sara LeMar, Paul Amador, et al. "Abstract 335: c-KIT targeted ETBs for cancer therapy and HSC transplant conditioning." Cancer Research 82, no. 12_Supplement (June 15, 2022): 335. http://dx.doi.org/10.1158/1538-7445.am2022-335.

Повний текст джерела

Анотація:

Abstract Engineered toxin bodies (ETBs) are next-generation immunotoxins that harbor an antibody-derived targeting domain and a cytotoxic payload derived from Shiga-like toxin-1 catalytic subunit A (SLTA). SLTA has been engineered to reduce innate immunogenicity and therefore increase the safety of ETBs whilst retaining potent cytotoxic properties. When targeted via a binding domain, SLTA is internalized and routes to the cytosol leading to irreversible ribosome inactivation and ultimately cell death. ETBs have been developed to treat a wide variety of cancers, including breast, lymphoma, multiple myeloma and PD-L1 positive solid tumors. This technology holds promise for non-oncology indications as well, particularly as a targeted and non-genotoxic conditioning regimen for hematopoietic stem cell (HSC) ablation to prepare patients for autologous stem cell transplant. c-KIT (CD117) is a well-known marker of hematopoietic stem and progenitor cells and is overexpressed in a high percentage of certain cancers including GIST, SCLC and AML. While tyrosine kinase inhibitors such as imatinib are effective therapies for c-KIT mutant GIST, resistance often occurs by the development of secondary mutations in the intracellular signaling domains. Thus, c-KIT represents a potential ETB target for both oncological and HSC transplant conditioning indications. Here we present data highlighting the in vitro potency and efficacy of CD117-targeting ETBs on cancer cell lines as well as on primary human CD34+ HSCs. CD117-targeted ETBs demonstrate exquisite specificity in vitro by killing only target positive CD34+ cells at picomolar potency while sparing the progenitors that lack CD117 expression. However, relatively low CD117 receptor levels on CD34+ HSCs prevent complete killing in vitro, limiting the observed efficacy. To overcome this challenge, an additional cytotoxic payload was conjugated to the ETB molecule to capitalize on ETBs’ unique internalization and routing properties to deliver a secondary mechanism of action. ETB-drug conjugates (ETB-DCs) exhibited improved cytotoxicity in vitro, especially in CD117-low target cells. Moving forward, we plan to explore both the ETB and the ETB-DC therapeutic index in vivo with a series of CD117+ tumor efficacy and HSC depletion models. Citation Format: Caleigh Howard, Shu Wiley, Wenzhao Dong, Andrea Mendiola, Veronica Partridge, Sara LeMar, Paul Amador, Amit K. Chaudhary, Joseph D. Dekker, Jay Zhao, Ross Durland, Aimee Iberg. c-KIT targeted ETBs for cancer therapy and HSC transplant conditioning [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 335.

Стилі APA, Harvard, Vancouver, ISO та ін.

50

Zarnecki, George. "La Sculpture Romane de la Route de Saint-Jacques. De Conques à Compostelle. By Marcel Durliat. 310 x 210mm. Pp. 508 + 475 figs. Mont-de-Marsan: CEHAG, 1990. ISBN 2-9501584-1-2. Fr. 530." Antiquaries Journal 70, no. 1 (March 1990): 144–45. http://dx.doi.org/10.1017/s0003581500070645.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Статті в журналах з теми "Durling"

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями